212 results on '"Khuroo, Arshad"'
Search Results
2. Clinical safety and pharmacokinetic evaluation of aqueous extract of Cocculus hirsutus, an anti-viral phytopharmacetical drug as a potential for the treatment of dengue and COVID-19
3. Multiple-reaction monitoring (MRM) LC–MS/MS quantitation of venlafaxine and its O-desmethyl metabolite for a preclinical pharmacokinetic study in rabbits
4. Arterolane–piperaquine–mefloquine versus arterolane–piperaquine and artemether–lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial
5. Bioequivalence study of oral pimavanserin capsule in healthy adult volunteers: Results from a randomized, crossover, open-label study
6. Bioavailability of once-daily amantadine extended-release tablets in healthy adult volunteers: Results from a randomized, crossover, open-label study
7. Simultaneous delivery of paclitaxel and erlotinib from dual drug loaded PLGA nanoparticles: Formulation development, thorough optimization and in vitro release
8. Sensitive LC-MS/MS Method for the Determination of Ramipril in Human Plasma: Application to a Bioequivalence Study in Indian Volunteers
9. Simultaneous estimation of paclitaxel and erlotinib in plasma by liquid chromatography/(+) electrospray tandem mass spectrometry: application in formulation development and pharmacokinetics
10. Quantitative estimation of irbesartan in two different matrices and its application to human and dog bioavailability studies using LC–MS/MS
11. Combining benefits of an adrenergic and a muscarinic blocker in a single formulation – A pharmacokinetic evaluation
12. Stability indicating LC-MS/MS method for estimation of lovastatin in human plasma: application to a bioequivalence study
13. Sensitive UHPLC-MS/MS Technique for Monitoring Levothyroxine (T4) in Human Serum Against Endogenous Thyroxin Level
14. Development of a bioanalytical method for the quantification of sinococuline in human plasma and its application in phase I clinical pharmacokinetic study
15. Comparison of Release Rates Derived from Cutaneous Versus Film-Forming Solution Containing Terbinafine: Approach Towards Qualification and Validation of In Vitro Parameters
16. Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: A single-dose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteers
17. Tandem Mass Spectrometry (MS/MS) in the Preclinical Pharmacokinetic Study of a Highly Prescribed SNRI Drug for Depression and Its Application to Oral Extended Release Solid Dosage Formulations in Rabbits
18. C1. The bioequivalence study design of highly variable drugs
19. Simultaneous determination of propranolol and 4-hydroxy propranolol in human plasma by solid phase extraction and liquid chromatography/electrospray tandem mass spectrometry
20. Simultaneous Determination of Atenolol and Chlorthalidone by LC–MS–MS in Human Plasma
21. A single-dose, randomized, open-label, two-period crossover bioequivalence study of a fixed-dose pediatric combination of lamivudine 40-mg, nevirapine 70-mg, and stavudine 10-mg tablet for oral suspension with individual liquid formulations in healthy adult male volunteers
22. PHARMACOKINETIC STUDY OF OLOPATADINE 10 MG EXTENDED RELEASE TABLET IN COMPARISON WITH OLOPATADINE 5 MG IMMEDIATE RELEASE TABLET IN INDIAN POPULATION
23. Bioequivalence of venlafaxine modified-release capsule revisited with an innovative approach using experimental and predictive models
24. The relative bioavailability of two formulations containing 10 mg Dapagliflozin assessed under fasting conditions in a randomized crossover study in healthy Caucasian subjects
25. Comparison of In Vitro Release Rates of Diclofenac Topical Formulations Using an In-Line Cell Automated Diffusion System
26. Sensitive UHPLC-MS/MS Technique for Monitoring Levothyroxine (T4) in Human Serum Against Endogenous Thyroxin Level
27. Liquid chromatographyâtandem mass spectrometry method for the estimation of adefovir in human plasma: Application to a pharmacokinetic study
28. RELATIVE BIOAVAILABILITY OF TWO FORMULATIONS CONTAINING DAPAGLIFLOZIN 10 MG UNDER FED CONDITION IN A RANDOMIZED CROSSOVER STUDY IN HEALTHY CAUCASIAN SUBJECTS.
29. Effect of Food on the Pharmacokinetics of Gliclazide 60 mg Modified Release Tablet in Healthy Caucasian Volunteers
30. Bioequivalence of Two Formulations of Gliclazide in a Randomized Crossover Study in Healthy Caucasian Subjects Under Fasting Conditions
31. Development, Validation and Successful Application of an In Vitro-In Vivo Correlation Model for Sustained Release Tablets of Bupropion Hydrochloride
32. Method development challenges and regulatory expectation in nifedipine
33. Role of RBC Partitioning and Whole Blood to Plasma Ratio in Bioanalysis: A Case Study With Valacyclovir and Acyclovir
34. KINETICS OF DAPAGLIFLOZIN AFTER SINGLE DOSE ORAL ADMINISTRATION OF A 10 MG IMMEDIATE RELEASE TABLET.
35. Bioequivalence of Two Formulations of Gliclazide in a Randomized Crossover Study in Healthy Caucasian Subjects Under Fasting Conditions.
36. Method development challenges and regulatory expectation in nifedipine
37. Development and Validation of ';Level A'; In Vitro - In Vivo Correlation for Extended Release Tablets of Lamotrigine
38. Clinical development of imatinib: an anticancer drug
39. BIOEQUIVALENCE OF TWO FORMULATIONS OF GLICLAZIDE IN A RANDOMIZED CROSSOVER STUDY IN HEALTHY CAUCASIAN SUBJECTS UNDER FED CONDITION.
40. Metaxalone estimation in biological matrix using high-throughput LC–MS/MS bioanalytical method
41. Effects of Sample Processing Techniques and Instrument Model on Matrix Effect in LC-MS/MS for a Model Drug
42. Liquid chromatography–tandem mass spectrometry method for the estimation of adefovir in human plasma: Application to a pharmacokinetic study
43. Simultaneous quantitation of atorvastatin and its two active metabolites in human plasma by liquid chromatography/(–) electrospray tandem mass spectrometry
44. Pharmacokinetic comparison and bioequivalence evaluation of losartan/ hydrochlorothiazide tablet between Asian Indian and Japanese volunteers
45. The pharmacodynamic equivalence of Orlistat 60 mg capsule. An open label, balanced, randomized, multiple-dose, cross-over pharmacodynamic end-point bioequivalence study in healthy, adult, human Asian Indian subjects under fed conditions
46. Development and validation of a LC-ESI-MS/MS method for simultaneous quantification of olmesartan and hydrochlothiazide in human K3 EDTA plasma and its application to pharmacokinetic biostudy
47. Liquid chromatography tandem mass spectrometry method for the estimation of lamotrigine in human plasma: Application to a pharmacokinetic study
48. Liquid chromatography tandem mass spectrometry method for the simultaneous stereoselective determination of venlafaxine and its major metabolite, O‐desmethylvenlafaxine, in human plasma
49. Determination of pharmacokinetics of itraconazole in healthy Indian subjects under fed condition and incurred sample analysis using a validated liquid chromatography tandem mass spectrometric method
50. Bioanalytical method development and validation using incurred samples: Quantitative estimation of metformin in human K3EDTA plasma by LC–MS/MS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.